In Vitro Antioxidant and In Vivo Lipid-Lowering Properties of Zingiber officinale Crude Aqueous Extract and Methanolic Fraction: A Follow-Up Study

Table 3

Changes of plasma, total cholesterol, and triglycerides (mmol.L⁻¹) in control and treated mice.

	4th week		8th week		12th week
	TC	TG	TC	TG	TC	TG
NCG	2.10 ± 0.11	1.07 ± 0.06	2.35 ± 0.15	1.21 ± 0.05	2.51 ± 0.13	1.48 ± 0.08
HCG	4.62 ± 0,25	2.49 ± 0.13	4.78 ± 0.22	2.52 ± 0.12	4.97 ± 0.30	2.83 ± 0.10
AETG dose 1	3.29 ± 0.19	2.25 ± 0.07	3.77 ± 0.18	2.33 ± 0.1	3.80 ± 0.12	2.45 ± 0.11
AETG dose 2	2.36 ± 0.09	1.61 ± 0.04	2.42 ± 0.11	1.75 ± 0.07	2.55 ± 0.10	1.92 ± 0.08
STG	2.20 ± 0.05	1.93 ± 0.05	2.35 ± 0.08	2.03 ± 0.07	2.41 ± 0.11	2.20 ± 0.13

Values are expressed as means ± SEM from ten mice in each lot; TC: total cholesterol; TG: triglycerides. HCG compared with NCG. AETG and STG compared with HCG. a: p < 0.001; c: p < 0.05; b: p < 0.01; NS: not significant.